ADIM
MNRO icon

Alpha DNA Investment Management’s Monro MNRO Stock Holding History

Alpha DNA Investment Management’s Portfolio MNRO Stock Details MNRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-23,940
Closed -$1.38M – 131
2021
Q3 		$1.38M Buy
+23,940
New +$1.4M 0.94% 72

Other funds holding MNRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alpha DNA Investment Management's MNRO Position: Q4 2021 in Review

Alpha DNA Investment Management sold out of Monro (MNRO) in Q4 2021, closing a stake of 23,940 shares — an estimated $1.38M sold.

Alpha DNA Investment Management first reported a position in MNRO in Q3 2021 and held it in 1 quarter. The position peaked at $1.38M in Q3 2021. 199 funds tracked by Wall St. Rank hold MNRO as of Q4 2021.

  • Alpha DNA Investment Management reported no remaining Monro position as of Q4 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 23,940 Monro shares in Q4 2021, an estimated $1.38M.
  • Alpha DNA Investment Management first reported a position in Monro in Q3 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Monro position peaked at $1.38M in Q3 2021.
  • 199 funds tracked by Wall St. Rank held Monro as of Q4 2021.

Based on Alpha DNA Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.